The Michigan Ovarian cancer Science and Innovation Consortium (MOSAIC) was founded in 2014 and brings together physicians and scientists from diverse disciplines to further the development and execution of ovarian cancer research. We currently have members from several top research institutions in Michigan, including the University of Michigan, Michigan State University, and The Van Andel Institute. These members have backgrounds in Public Health, Materials Science and Engineering, Biomedical Engineering, Internal Medicine, Hematology/Oncology,  Gynecologic Oncology, Medicinal Chemistry, and Epigenetics. We have regular meetings where we discuss current research, present ideas for future collaborations within the group and drive logistics for current endeavors forward.

​The primary objective of this group is to improve understanding of ovarian cancer prevention, treatment and survival through novel approaches by a multidisciplinary team. The aim of our group is to provide a collaborative space for a diverse group of scientists to draw from each other’s expertise.

In America, about 50% of men and 33% of women will have cancer in their lifetime. While some cancers are better understood, others, like ovarian cancer lag behind. Advances in understanding ovarian cancer not only help those suffering from ovarian cancer, but shed light on other hormone-related cancers as well. Ovarian cancer kills around 15,000 women in the U.S. each year. There is currently no early detection method, and treatment options are limited.